APA (7th ed.) Citation

M, J., AM, E., L, L., SF, S., M, L., A, K., . . . DE, N. (2024). Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: A longitudinal phase 2b randomised controlled trial. The Lancet. Infectious diseases, 24(9), 1025. https://doi.org/10.1016/S1473-3099(24)00179-8

Chicago Style (17th ed.) Citation

M, Juraska, et al. "Genotypic Analysis of RTS,S/AS01E Malaria Vaccine Efficacy Against Parasite Infection as a Function of Dosage Regimen and Baseline Malaria Infection Status in Children Aged 5-17 Months in Ghana and Kenya: A Longitudinal Phase 2b Randomised Controlled Trial." The Lancet. Infectious Diseases 24, no. 9 (2024): 1025. https://doi.org/10.1016/S1473-3099(24)00179-8.

MLA (9th ed.) Citation

M, Juraska, et al. "Genotypic Analysis of RTS,S/AS01E Malaria Vaccine Efficacy Against Parasite Infection as a Function of Dosage Regimen and Baseline Malaria Infection Status in Children Aged 5-17 Months in Ghana and Kenya: A Longitudinal Phase 2b Randomised Controlled Trial." The Lancet. Infectious Diseases, vol. 24, no. 9, 2024, p. 1025, https://doi.org/10.1016/S1473-3099(24)00179-8.